Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-15 Sale | 2022-11-17 4:33 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $48.01 | $60,013 | 790,503 (Indirect Direct) | View |
| 2022-11-08 Sale | 2022-11-10 08:30 am | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $46.47 | $557,640 | 1,184,774 (Direct) | View |
| 2022-11-03 Sale | 2022-11-07 4:19 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $58.54 | $292,700 | 355,407 (Direct) | View |
| 2022-11-01 Sale | 2022-11-03 4:28 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 500 | $60.83 | $30,415 | 402,464 (Indirect Direct) | View |
| 2022-11-01 Sale | 2022-11-03 4:27 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico Chief Medical Officer | 2,500 | $60.83 | $152,075 | 99,884 (Direct) | View |
| 2022-10-14 Sale | 2022-10-17 5:57 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $59.31 | $74,138 | 791,753 (Indirect Direct) | View |
| 2022-10-10 Sale | 2022-10-11 4:58 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $57.5 | $690,000 | 1,196,774 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 5:14 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 2,500 | $66.69 | $166,725 | 102,384 (Direct) | View |
| 2022-10-03 Sale | 2022-10-05 5:12 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $66.69 | $333,450 | 360,407 (Direct) | View |
| 2022-09-15 Sale | 2022-09-16 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $66 | $82,500 | 793,003 (Indirect Direct) | View |
| 2022-09-08 Sale | 2022-09-12 4:52 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $63.98 | $767,760 | 1,208,774 (Direct) | View |
| 2022-09-08 Sale | 2022-09-08 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 15,000 | $65 | $975,000 | 402,964 (Indirect Direct) | View |
| 2022-09-06 Sale | 2022-09-07 4:37 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $60.38 | $301,900 | 365,407 (Direct) | View |
| 2022-09-01 Sale | 2022-09-02 4:22 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 2,500 | $60.3 | $150,750 | 104,884 (Direct) | View |
| 2022-08-17 Sale | 2022-08-18 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $69.5 | $347,500 | 29,250 (Direct) | View |
| 2022-08-15 Sale | 2022-08-16 5:04 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $69 | $862,500 | 370,407 (Direct) | View |
| 2022-08-15 Sale | 2022-08-16 5:00 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $67.21 | $84,012 | 794,253 (Indirect Direct) | View |
| 2022-08-11 Sale | 2022-08-12 5:01 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $67 | $837,500 | 382,907 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 4:58 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $67 | $335,000 | 34,250 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 4:57 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 30,000 | $65.63 | $1,968,900 | 388,264 (Indirect Direct) | View |
| 2022-08-08 Sale | 2022-08-09 5:22 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $65 | $812,500 | 395,407 (Direct) | View |
| 2022-08-08 Sale | 2022-08-09 5:18 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $62.5 | $750,000 | 1,220,774 (Direct) | View |
| 2022-08-08 Sale | 2022-08-09 5:16 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $64.5 | $322,500 | 39,250 (Direct) | View |
| 2022-08-04 Sale | 2022-08-08 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 10,000 | $60.75 | $607,500 | 44,250 (Direct) | View |
| 2022-08-03 Sale | 2022-08-04 6:40 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $56.43 | $282,150 | 407,907 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER | 2,500 | $55.99 | $139,975 | 107,384 (Direct) | View |
| 2022-07-27 Sale | 2022-07-28 4:03 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $57 | $285,000 | 54,250 (Direct) | View |
| 2022-07-19 Sale | 2022-07-21 4:31 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $56.42 | $282,100 | 59,250 (Direct) | View |
| 2022-07-15 Sale | 2022-07-18 5:29 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $46.33 | $57,913 | 795,503 (Indirect Direct) | View |
| 2022-04-21 Sale | 2022-07-12 5:55 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $48.42 | $242,100 | 414,782 (Direct) | View |
| 2022-07-08 Sale | 2022-07-12 4:04 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,000 | $47.95 | $575,400 | 1,534,268 (Direct) | View |
| 2022-06-27 Sale | 2022-06-29 4:18 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 1,341 | $46.79 | $62,743 | 287,022 (Indirect) | View |
| 2022-06-23 Sale | 2022-06-24 5:15 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 15,000 | $45 | $675,000 | 285,679 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-15 Exercise | 2022-11-17 4:33 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 790,503 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-17 4:33 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 790,503 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 08:30 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,184,774 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 08:30 am | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,184,774 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-07 4:19 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 355,407 (Direct) | View |
| 2022-11-03 Exercise | 2022-11-07 4:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 355,407 (Direct) | View |
| 2022-10-26 Tax Withholding | 2022-10-28 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead | 130 | $58.41 | 24,844 (Direct) | View |
| 2022-10-20 Tax Withholding | 2022-10-24 5:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 196 | $58 | 29,054 (Direct) | View |
| 2022-10-20 Tax Withholding | 2022-10-24 5:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George CAO | 130 | $58 | 18,451 (Direct) | View |
| 2022-10-14 Exercise | 2022-10-17 5:57 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 791,753 (Direct) | View |
| 2022-10-14 Exercise | 2022-10-17 5:57 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 791,753 (Direct) | View |
| 2022-10-10 Exercise | 2022-10-11 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,196,774 (Direct) | View |
| 2022-10-10 Exercise | 2022-10-11 4:58 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,196,774 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:12 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 360,407 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 360,407 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-16 4:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 793,003 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-16 4:03 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 793,003 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-12 4:52 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,208,774 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-12 4:52 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,208,774 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 4:37 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 365,407 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 4:37 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 365,407 (Direct) | View |
| 2022-08-30 Tax Withholding | 2022-08-31 4:26 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George CAO | 558 | $58.84 | 18,581 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-26 4:06 pm | N/A 2028-12-31 | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 4,306 | $0 | 431,238 (Direct) | View |
| 2022-08-25 Exercise | 2022-08-26 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 4,306 | $13.19 | 431,238 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-18 4:02 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $0 | 29,250 (Direct) | View |
| 2022-08-17 Exercise | 2022-08-18 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $15.52 | 29,250 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-17 5:08 pm | N/A 2027-11-08 | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 25,394 | $0 | 413,658 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-17 5:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 25,394 | $14 | 413,658 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:04 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 370,407 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 370,407 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:00 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 794,253 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 5:00 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 794,253 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 5:01 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 382,907 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 5:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 382,907 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:58 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $0 | 34,250 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $15.52 | 34,250 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:22 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $0 | 395,407 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:22 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 12,500 | $15.09 | 395,407 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:18 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,220,774 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:18 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,220,774 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:16 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $0 | 39,250 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-09 5:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $15.52 | 39,250 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:02 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 10,000 | $0 | 44,250 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 10,000 | $15.52 | 44,250 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 6:40 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 407,907 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 6:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 407,907 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-28 4:03 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $0 | 54,250 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-28 4:03 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $15.52 | 54,250 (Direct) | View |
| 2022-07-21 Exercise | 2022-07-22 4:01 pm | N/A 2027-11-08 | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 9,606 | $0 | 443,658 (Direct) | View |
| 2022-07-21 Exercise | 2022-07-22 4:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 9,606 | $14 | 443,658 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:31 pm | N/A 2028-02-04 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $0 | 59,250 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 4:31 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey VP | 5,000 | $15.52 | 59,250 (Direct) | View |
| 2022-07-15 Exercise | 2022-07-18 5:29 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $2.67 | 795,503 (Direct) | View |
| 2022-07-15 Exercise | 2022-07-18 5:29 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 1,250 | $0 | 795,503 (Direct) | View |
| 2022-04-21 Other | 2022-07-12 5:55 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 13,125 | $0 | 414,782 (Direct) | View |
| 2022-04-21 Exercise | 2022-07-12 5:55 pm | N/A 2028-11-15 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $0 | 414,782 (Direct) | View |
| 2022-04-21 Exercise | 2022-07-12 5:55 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 5,000 | $15.09 | 414,782 (Direct) | View |
| 2022-07-08 Exercise | 2022-07-12 4:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $2.67 | 1,534,268 (Direct) | View |
| 2022-07-08 Exercise | 2022-07-12 4:04 pm | N/A 2023-12-05 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 18,500 | $0 | 1,534,268 (Direct) | View |